QFR-guided versus IVUS-guided with QFR confirmation for drug-coated balloon treatment of non-complex coronary lesions: a single-centre pilot randomised trial
This single-center pilot randomized trial demonstrated that both QFR-guided and IVUS+QFR-guided strategies are feasible for drug-coated balloon treatment of non-complex coronary lesions, with no statistically significant difference in immediate functional success rates, thereby providing essential effect size estimates for designing future confirmatory studies.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human heart relies on a network of arteries to deliver oxygen-rich blood to its muscle. When these vessels narrow due to plaque buildup, the heart struggles, often causing chest pain or leading to a heart attack. For decades, doctors have treated these blockages by threading a tiny balloon into the artery to widen it, often leaving behind a metal mesh tube called a stent to hold the vessel open permanently. While effective, these metal implants are foreign objects that remain in the body forever, carrying risks of long-term complications like the vessel narrowing again around the metal or forming dangerous blood clots. To avoid leaving anything behind, a newer approach uses a drug-coated balloon. This device inflates inside the narrowed artery to stretch it open and delivers a medication that stops the tissue from growing back too quickly, then is removed entirely, leaving the artery free of permanent hardware.
However, using a balloon without a stent is a delicate balancing act. If the artery is not prepared perfectly before the drug is applied, the vessel can spring back to its narrow state or tear, causing the treatment to fail. Doctors need a way to know exactly when the job is done. One method involves using a camera inside the artery to see the physical shape of the vessel, while another uses a mathematical calculation based on X-ray images to measure how well blood is actually flowing through the narrowed spot. A recent study from Hangzhou, China, set out to compare these two ways of guiding the procedure to see which leads to better immediate results for patients with non-complex blockages.
The researchers conducted a small, early-stage experiment involving 78 patients who were scheduled to receive this drug-coated balloon treatment. They split the patients into two groups to test different decision-making strategies during the surgery. In the first group, the doctors relied primarily on a functional assessment called the quantitative flow ratio. This tool analyzes standard X-ray images to calculate a score representing how well blood is flowing, aiming for a score of 0.90 or higher to confirm the artery is open enough. In the second group, the doctors used a combination of an internal ultrasound camera to check the physical structure of the artery and the same flow calculation to double-check their work. The ultrasound acts like a high-resolution cross-section, showing the size of the vessel and the thickness of the plaque, while the flow calculation serves as a final verification that the blood is moving freely.
The study was designed as a pilot, meaning its main goal was not to declare one method the winner, but to see if the approach was feasible and to gather enough data to plan a much larger study in the future. Every patient in the trial completed the procedure, and the researchers were able to measure the final blood flow scores for all 82 treated vessels. The results showed that both strategies worked well. In the group guided by flow calculations alone, about 79 percent of the vessels achieved the target score for successful treatment. In the group that used the internal ultrasound camera plus the flow check, about 85 percent of the vessels reached the target.
While the group with the ultrasound camera had a slightly higher success rate, the difference was small enough that it could easily be due to chance rather than a true advantage of one method over the other. The researchers noted that the range of possible outcomes was wide, meaning they could not say with certainty that one strategy was better than the other. They did observe that in the group using the ultrasound camera, a few patients required a stent to be placed because the artery showed signs of tearing or instability that the camera revealed, whereas no patients in the flow-calculation-only group needed a stent. However, because so few stents were needed, this finding was too small to draw a firm conclusion about safety.
The study also looked at how well the doctors' pre-procedure planning matched the actual results. In the group that used the flow calculation tool to plan the surgery, the predicted improvement in blood flow was slightly higher than what was actually measured after the balloon was inflated. This suggests that while the planning tool is useful, the real-world outcome of stretching a vessel with a drug-coated balloon is slightly different from the computer simulation, likely because the artery's physical behavior after the balloon is removed is complex and hard to predict perfectly.
Ultimately, the researchers found that both methods are safe and feasible for guiding this type of treatment. The study did not prove that one approach is superior, but it provided a clear roadmap for future, larger trials. By confirming that these procedures can be performed successfully and by estimating how many patients would be needed to detect a real difference between the methods, the study lays the groundwork for more definitive research. The findings suggest that doctors have multiple valid tools to ensure the artery is open and blood is flowing, and that the choice of tool may depend on the specific needs of the patient and the available technology, rather than one single method being the only correct answer.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.